---
figid: PMC12236749__ijmm-56-03-05570-g01
figtitle: BMSC-Exos ameliorate MI
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12236749
filename: ijmm-56-03-05570-g01.jpg
figlink: /pmc/articles/PMC12236749/figure/F2/
number: F2
caption: BMSC-Exos ameliorate MI. miR-214, miR-181a-5p and miR-21 in BMSC-Exos can
  inhibit CaMKII and ATF2 expression, respectively and regulate the PTEN/PI3K/AKT
  axis, resulting in downregulation of ROS and MDA expression upregulation of SOD
  and then inhibit MI oxidative stress. In addition, miR-182-5p and other molecules
  in BMSC-Exos can inhibit MI inflammation by suppressing the TLR4/NF-κB pathway,
  reducing LOX-1 and NLRP3 inflammasome expression, regulating macrophage polarization,
  or activating the Nrf2/HO-1 axis, thereby suppressing the release of pro-inflammatory
  factors while upregulating anti-inflammatory cytokines IL-10 expression. BMSC-derived
  exosomal miR-125b-5p and miR-301 can suppress p53/Bnip3 signaling, reduce the LC3-II/I
  ratio and inhibit excessive autophagy. BMSC-Exos can also promote the expression
  of Beclin-1, ATG13 and LC3-II, while decreasing P62 gene expression to enhance protective
  autophagy, improving MI. Notably, miR-210, miR-338 and miR-144 in BMSC-Exos can
  inhibit AIFM3/P53, PI3K/AKT, MAP3K2/JNK and PTEN/AKT signaling pathways, while BMSC-Exos
  with low expression of miR-153-3p can activate ANGPT1-mediated VEGF/PI3K/AKT/eNOS
  signaling, thereby inhibiting apoptosis. ITCH carried by BMSC-Exos enhances ASK1
  ubiquitination and degradation. BMSC-Exos containing lncRNA-UCAI, miR-125b-5p and
  others can upregulate miR-24 in CMCs and inhibit apoptosis via the miR-873-5p/XIAP
  axis, exerting cardioprotective effects. miR-29b-3p and miR-411 in BMSC-Exos target
  and inhibit ADAMTS16 and HIF-1α, enhance VEGF secretion and increase capillary density,
  thereby promoting angiogenesis after MI. miR-19a/19b, miR-129-5p, miR-1180-3p and
  other molecules in BMSC-Exos can inhibit EZH2 to promote HMGA2 expression and activate
  the PI3K/AKT pathway, or inhibit ETS1 signaling to downregulate collagen I, collagen
  III and TGF-β1, alleviating cardiac fibrosis. BMSC-Exos, bone marrow mesenchymal
  stem cell-derived exosomes; MI, myocardial infarction; miR/miRNA, microRNA; CaMKII,
  calcium-calmodulin-dependent protein kinase II; ATF2, activating transcription factor
  2; PTEN, phosphatase and tensin homolog deleted on chromosome ten; PI3K, phosphatidylinositol
  3-kinase; AKT, protein kinase B; ROS, reactive oxygen species; MDA, malondialdehyde;
  SOD, superoxide dismutase; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB;
  LOX-1, lectin-like oxidized low-density lipoprotein receptor-1; NLRP3, nucleotide-binding
  domain and leucine-rich repeat pyrin domain-containing-3; Nrf2, nuclear factor erythroid
  2-related factor 2; HO-1, heme oxygenase-1; Bnip3, Bcl-2/adenovirus E1B 19-kDa interacting
  protein 3; LC3-II, microtubule-associated protein 1 light chain 3-II; Beclin-1,
  Bcl-2-interacting protein 1; ATG13, autophagy-related protein 13; AIFM3, apoptosis-inducing
  factor, mitochondrion-associated 3; MAP3K2, mitogen-activated protein kinase kinase
  kinase 2; JNK, c-Jun N-terminal kinase; ANGPT1, angiopoietin 1; VEGF, vascular endothelial
  growth factor; eNOS, endothelial nitric oxide synthase; ITCH, itchy E3 ubiquitin
  ligase; ASK1, apoptosis signal-regulated kinase-1; ADAMTS16, a disintegrin-like
  metalloproteinase with thrombospondin motifs-16; HIF-1α, hypoxia-inducible factor-1;
  EZH2, enhancer of zeste 2 polycomb repressive complex 2 subunit; HMGA2, high mobility
  group AT-hook 2; ETS1, ETS proto-oncogene 1; TGF-β1, transforming growth factor-β1
papertitle: 'Exosome-mediated crosstalk between the cardiovascular and musculoskeletal
  systems: Mechanisms and therapeutic potential (Review)'
reftext: Qingchen Li, et al. Int J Mol Med. 2025 Sep;56(3).
year: '2025'
doi: 10.3892/ijmm.2025.5570
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: Spandidos Publications
keywords: cardiovascular system | musculoskeletal system | exosome | crosstalk | mechanism
  | clinical application
automl_pathway: 0.9120668
figid_alias: PMC12236749__F2
figtype: Figure
redirect_from: /figures/PMC12236749__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12236749__ijmm-56-03-05570-g01.html
  '@type': Dataset
  description: BMSC-Exos ameliorate MI. miR-214, miR-181a-5p and miR-21 in BMSC-Exos
    can inhibit CaMKII and ATF2 expression, respectively and regulate the PTEN/PI3K/AKT
    axis, resulting in downregulation of ROS and MDA expression upregulation of SOD
    and then inhibit MI oxidative stress. In addition, miR-182-5p and other molecules
    in BMSC-Exos can inhibit MI inflammation by suppressing the TLR4/NF-κB pathway,
    reducing LOX-1 and NLRP3 inflammasome expression, regulating macrophage polarization,
    or activating the Nrf2/HO-1 axis, thereby suppressing the release of pro-inflammatory
    factors while upregulating anti-inflammatory cytokines IL-10 expression. BMSC-derived
    exosomal miR-125b-5p and miR-301 can suppress p53/Bnip3 signaling, reduce the
    LC3-II/I ratio and inhibit excessive autophagy. BMSC-Exos can also promote the
    expression of Beclin-1, ATG13 and LC3-II, while decreasing P62 gene expression
    to enhance protective autophagy, improving MI. Notably, miR-210, miR-338 and miR-144
    in BMSC-Exos can inhibit AIFM3/P53, PI3K/AKT, MAP3K2/JNK and PTEN/AKT signaling
    pathways, while BMSC-Exos with low expression of miR-153-3p can activate ANGPT1-mediated
    VEGF/PI3K/AKT/eNOS signaling, thereby inhibiting apoptosis. ITCH carried by BMSC-Exos
    enhances ASK1 ubiquitination and degradation. BMSC-Exos containing lncRNA-UCAI,
    miR-125b-5p and others can upregulate miR-24 in CMCs and inhibit apoptosis via
    the miR-873-5p/XIAP axis, exerting cardioprotective effects. miR-29b-3p and miR-411
    in BMSC-Exos target and inhibit ADAMTS16 and HIF-1α, enhance VEGF secretion and
    increase capillary density, thereby promoting angiogenesis after MI. miR-19a/19b,
    miR-129-5p, miR-1180-3p and other molecules in BMSC-Exos can inhibit EZH2 to promote
    HMGA2 expression and activate the PI3K/AKT pathway, or inhibit ETS1 signaling
    to downregulate collagen I, collagen III and TGF-β1, alleviating cardiac fibrosis.
    BMSC-Exos, bone marrow mesenchymal stem cell-derived exosomes; MI, myocardial
    infarction; miR/miRNA, microRNA; CaMKII, calcium-calmodulin-dependent protein
    kinase II; ATF2, activating transcription factor 2; PTEN, phosphatase and tensin
    homolog deleted on chromosome ten; PI3K, phosphatidylinositol 3-kinase; AKT, protein
    kinase B; ROS, reactive oxygen species; MDA, malondialdehyde; SOD, superoxide
    dismutase; TLR4, toll-like receptor 4; NF-κB, nuclear factor-κB; LOX-1, lectin-like
    oxidized low-density lipoprotein receptor-1; NLRP3, nucleotide-binding domain
    and leucine-rich repeat pyrin domain-containing-3; Nrf2, nuclear factor erythroid
    2-related factor 2; HO-1, heme oxygenase-1; Bnip3, Bcl-2/adenovirus E1B 19-kDa
    interacting protein 3; LC3-II, microtubule-associated protein 1 light chain 3-II;
    Beclin-1, Bcl-2-interacting protein 1; ATG13, autophagy-related protein 13; AIFM3,
    apoptosis-inducing factor, mitochondrion-associated 3; MAP3K2, mitogen-activated
    protein kinase kinase kinase 2; JNK, c-Jun N-terminal kinase; ANGPT1, angiopoietin
    1; VEGF, vascular endothelial growth factor; eNOS, endothelial nitric oxide synthase;
    ITCH, itchy E3 ubiquitin ligase; ASK1, apoptosis signal-regulated kinase-1; ADAMTS16,
    a disintegrin-like metalloproteinase with thrombospondin motifs-16; HIF-1α, hypoxia-inducible
    factor-1; EZH2, enhancer of zeste 2 polycomb repressive complex 2 subunit; HMGA2,
    high mobility group AT-hook 2; ETS1, ETS proto-oncogene 1; TGF-β1, transforming
    growth factor-β1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MIR214
  - MIR21
  - CAMK2G
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - SOD1
  - TLR4
  - NFKB1
  - OLR1
  - NLRP3
  - IL6
  - IL1A
  - IL1B
  - TNF
  - GABPA
  - NFE2L2
  - HMOX1
  - DYNLL1
  - MAP1LC3A
  - MIR301A
  - BNIP3
  - TP53
  - TP63
  - TP73
  - ATF7IP
  - ATG13
  - AIFM3
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - MIR210
  - MIR338
  - MAP3K2
  - MAPK8
  - MAPK9
  - MAPK10
  - BAX
  - MIR144
  - ITCH
  - ANGPT1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - NOS3
  - ENO4
  - KDR
  - MAP3K5
  - BLCAP
  - CHMP2A
  - ADAMTS16
  - MIR411
  - HIF1A
  - XIAP
  - MIR19A
  - EZH2
  - HMGA2
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - TGFB1
  - ROS
  - MDA
  - TNF-a
  - Collagen
---
